Ascend Laboratories
Failed Dissolution Specifications
Yes — there is an active recall. 9 ongoing FDA recalls mention Metoprolol (43 total). Check the affected lots below.
Most common reason: Dissolution failure (19 of these recalls)
Recalls are matched by product description. A recall usually affects specific lots, not every package of Metoprolol. “Active” means an FDA recall is still ongoing; “closed” means it was terminated or completed. Checked against openFDA on Oct 10, 2026.
Failed Dissolution Specifications
Failed Dissolution Specifications
Failed Dissolution Specifications
Failed Dissolution Specifications
Failed Dissolution Specifications
CGMP Deviations: Presence of a nitrosamine, N-nitroso-metoprolol above the established Acceptable Daily Intake (ADI) level.
CGMP Deviations: Presence of a nitrosamine, N-nitroso-metoprolol above the established Acceptable Daily Intake (ADI) level.
Failed Dissolution Specifications: Product failed to meet dissolution acceptance criteria in the stability studies at the 6th month (25¿C/60% RH) long-term.
Presence of Foreign Substance: metal in tablet
Failed Dissolution Specifications: This recall is being initiated in support of the recall by the manufacturer which included lots that were packaged for BluePoint Laboratories.
Failed Dissolution Specification
Failed Dissolution Specification
Failed Dissolution Specification
cGMP deviations: Temperature abuse
CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions.
Failed Dissolution Specifications.
Complaint received of foreign matter (metal) embedded in tablet.
Failed Dissolution Specifications
Presence of Foreign Substance: Product complaints received for the presence of metal wire in one tablet.
CGMP Deviations: Intermittent exposure to temperature excursion during storage.
Failed pH Specifications: High Out-of-Specification results for pH were obtained during stability testing.
Failed dissolution specifications: Out-of-Specification dissolution test result obtained during routine stability testing.
Failed pH Specifications: Upward shift in the pH of the solution within the shelf life of the impacted lots.
Presence of Foreign Tablets/Capsules: One foreign tablet identified as Clopidogrel 75 mg was found in a 100 count bottle of Metoprolol Succiante Extended-Release Tablets.
CGMP Deviations: Firm did not adequately investigate customer complaints.
Free recall alerts
Tell us what you take. When FDA posts a recall announcement or classifies a recall for one of your medications, we email you in plain English, with what to check. No account needed.